These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22387157)

  • 1. Action naming in Parkinson's disease patients on/off dopamine.
    Herrera E; Cuetos F
    Neurosci Lett; 2012 Apr; 513(2):219-22. PubMed ID: 22387157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verbal fluency in Parkinson's disease patients on/off dopamine medication.
    Herrera E; Cuetos F; Ribacoba R
    Neuropsychologia; 2012 Dec; 50(14):3636-40. PubMed ID: 22995942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of motion content in action naming by Parkinson's disease patients.
    Herrera E; Rodríguez-Ferreiro J; Cuetos F
    Cortex; 2012 Jul; 48(7):900-4. PubMed ID: 21247557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
    Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic medication boosts action-effect binding in Parkinson's disease.
    Moore JW; Schneider SA; Schwingenschuh P; Moretto G; Bhatia KP; Haggard P
    Neuropsychologia; 2010 Mar; 48(4):1125-32. PubMed ID: 20018200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of levodopa on both verbal and motor representations of action in Parkinson's disease: a fMRI study.
    Péran P; Nemmi F; Méligne D; Cardebat D; Peppe A; Rascol O; Caltagirone C; Demonet JF; Sabatini U
    Brain Lang; 2013 Jun; 125(3):324-9. PubMed ID: 22841350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered directional connectivity in Parkinson's disease during performance of a visually guided task.
    Tropini G; Chiang J; Wang ZJ; Ty E; McKeown MJ
    Neuroimage; 2011 Jun; 56(4):2144-56. PubMed ID: 21402160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine modulation affects the performance of parkinsonian patients in a precision motor task measured by an antropomorphic device.
    Nombela C; Pedreño-Molina JL; Ros-Bernal F; Molina-Vilaplana J; Fdez-Villalba E; López-Coronado J; Herrero MT
    Hum Mov Sci; 2012 Jun; 31(3):730-42. PubMed ID: 22414696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to sensory uncertainty in Parkinson's disease: a marker of cerebellar dysfunction?
    Stevenson JK; Oishi MM; Farajian S; Cretu E; Ty E; McKeown MJ
    Eur J Neurosci; 2011 Jan; 33(2):298-305. PubMed ID: 21155903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor program memory storage in Parkinson's disease patients tested with a delayed response task.
    Labutta RJ; Miles RB; Sanes JN; Hallett M
    Mov Disord; 1994 Mar; 9(2):218-22. PubMed ID: 8196687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.
    Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
    Behav Brain Res; 2012 Apr; 230(1):116-24. PubMed ID: 22343069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
    Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.
    Willemssen R; Falkenstein M; Schwarz M; Müller T; Beste C
    Neurobiol Aging; 2011 Feb; 32(2):327-35. PubMed ID: 19269061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Word processing in Parkinson's disease is impaired for action verbs but not for concrete nouns.
    Boulenger V; Mechtouff L; Thobois S; Broussolle E; Jeannerod M; Nazir TA
    Neuropsychologia; 2008 Jan; 46(2):743-56. PubMed ID: 18037143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.